{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T12:09:59Z","timestamp":1784030999288,"version":"3.55.0"},"reference-count":35,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2007,4,11]],"date-time":"2007-04-11T00:00:00Z","timestamp":1176249600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J American Geriatrics Society"],"published-print":{"date-parts":[[2007,5]]},"abstract":"<jats:p>\n                    <jats:bold>OBJECTIVES:<\/jats:bold>\n                    To determine whether secondary hyperparathyroidism (HPTH) due to hypovitaminosis D affects bone mineral density (BMD) response to alendronate (ALN) in elderly women with osteoporosis.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>DESIGN:<\/jats:bold>\n                    Randomized, controlled trial with 1\u2010year follow\u2010up.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>SETTING:<\/jats:bold>\n                    Two osteoporosis centers in northern Italy.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>PARTICIPANTS:<\/jats:bold>\n                    Community\u2010dwelling women aged 60 and older with a BMD T\u2010score below \u20132.5 and secondary HPTH with vitamin D insufficiency.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>INTERVENTION:<\/jats:bold>\n                    One hundred twenty subjects were randomly assigned to receive ALN 70 mg once a week alone or ALN 70 mg once a week plus calcitriol (1,25D3) 0.5 \u03bcg daily.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>MEASUREMENTS:<\/jats:bold>\n                    BMD measured using dual\u2010energy x\u2010ray absorptiometry at the lumbar spine (L1\u2010L4), femoral neck, and total hip and serum levels of intact PTH at baseline and 12 months.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>RESULTS:<\/jats:bold>\n                    After 1 year, BMD of the lumbar spine, femoral neck, and total hip significantly increased from baseline in both groups (\n                    <jats:italic>P<\/jats:italic>\n                    &lt;.001). Patients allocated to ALN plus 1,25D3 demonstrated a significantly higher increase in lumbar spine BMD than those receiving ALN alone (mean percentage\u00b1standard deviation 6.8\u00b14.6 vs 3.7\u00b13.2,\n                    <jats:italic>P<\/jats:italic>\n                    &lt;.001). Serum levels of PTH did not change significantly at 1 year in the ALN group (mean percentage, \u22123.7\u00b127.1,\n                    <jats:italic>P<\/jats:italic>\n                    =.13) but decreased significantly in the ALN plus 1,25D3 group (\u221232.1\u00b122.1,\n                    <jats:italic>P<\/jats:italic>\n                    &lt;.001). At 12 months, subjects with normalized PTH independent of therapy allocation had a greater increase in lumbar spine BMD than those with persistent HPTH (6.5\u00b14.6% vs 3.7\u00b13.4%,\n                    <jats:italic>P<\/jats:italic>\n                    &lt;.001). Lumbar spine BMD changes showed a significant negative correlation with PTH at 1 year (correlation coefficient (\n                    <jats:italic>\u03c1<\/jats:italic>\n                    ) =\u22120.399,\n                    <jats:italic>P<\/jats:italic>\n                    &lt;.001) and a positive correlation with PTH changes (i.e., baseline value \u2013 1 year value;\n                    <jats:italic>\u03c1<\/jats:italic>\n                    =0.295,\n                    <jats:italic>P<\/jats:italic>\n                    =.005).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>CONCLUSION:<\/jats:bold>\n                    Persistence of secondary HPTH reduces BMD response to ALN in older women with osteoporosis.\n                  <\/jats:p>","DOI":"10.1111\/j.1532-5415.2007.01161.x","type":"journal-article","created":{"date-parts":[[2007,4,26]],"date-time":"2007-04-26T04:34:09Z","timestamp":1177562049000},"page":"752-757","source":"Crossref","is-referenced-by-count":54,"title":["Secondary Hyperparathyroidism Due to Hypovitaminosis D Affects Bone Mineral Density Response to Alendronate in Elderly Women with Osteoporosis: A Randomized Controlled Trial"],"prefix":"10.1111","volume":"55","author":[{"given":"Antonella","family":"Barone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Giusti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Pioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Girasole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Razzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Pizzonia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Palummeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerolamo","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,4,11]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.11.4125"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.81.3.1129"},{"key":"e_1_2_7_4_2","first-page":"1212","article-title":"A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis","volume":"86","author":"Lips P","year":"2001","journal-title":"Baseline data from the multiple outcomes of raloxifene evaluation clinical trial"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03347375"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-005-1910-8"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001980070024"},{"key":"e_1_2_7_8_2","first-page":"477","article-title":"Vitamin D deficiency and secondary hyperparathyroidism in the elderly","volume":"22","author":"Lips P.","year":"2001","journal-title":"Consequences for bone loss and fractures and therapeutic implications"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199212033272305"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.80.11.3304"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01623440"},{"key":"e_1_2_7_12_2","first-page":"2142","article-title":"Determinants of bone mineral density in older men and women","volume":"16","author":"Pluijm SMF","year":"2001","journal-title":"Body composition as mediator"},{"key":"e_1_2_7_13_2","first-page":"1221","article-title":"Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss","volume":"19","author":"Meier C","year":"2004","journal-title":"A randomized controlled open-label prospective trial"},{"issue":"10","key":"e_1_2_7_14_2","first-page":"S1","article-title":"for the Scientific Advisory Council of the Osteoporosis Society of Canada: 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada","volume":"167","author":"Brown JP","year":"2002","journal-title":"Can Med Assoc J"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01623782"},{"key":"e_1_2_7_16_2","first-page":"293","article-title":"American Association of Clinical Endocrinologists 2001 medical guidelines for clinical practice for the prevention and management of postmenopausal osteoporosis","volume":"7","author":"Hodgson SF","year":"2001","journal-title":"Endocr Pract"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.6.785"},{"key":"e_1_2_7_18_2","first-page":"637","article-title":"Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene","volume":"282","author":"Ettinger B","year":"1999","journal-title":"Results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01623005"},{"key":"e_1_2_7_20_2","first-page":"1344","article-title":"Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis","volume":"282","author":"Harris ST","year":"1999","journal-title":"A randomized controlled trial. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group"},{"key":"e_1_2_7_21_2","first-page":"141","article-title":"Treatment with once\u2010weekly alendronate 70 mg compared with once\u2010weekly risedronate 35 mg in women with postmenopausal osteoporosis","volume":"20","author":"Rosen CJ","year":"2005","journal-title":"A randomised double-blind study"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1159\/000180580"},{"key":"e_1_2_7_23_2","first-page":"309","article-title":"Sample size estimation","volume":"227","author":"Eng J.","year":"2003","journal-title":"How many individuals should be studied?"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1185\/030079905X61875"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199709043371003"},{"key":"e_1_2_7_26_2","first-page":"257","article-title":"Combined calcium and vitamin D3 supplementation in elderly women","volume":"13","author":"Chapuy MC","year":"2002","journal-title":"Confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: The Decalyos II Study"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00223001118"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/PL00004171"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03339822"},{"issue":"1","key":"e_1_2_7_30_2","first-page":"S296","article-title":"Vitamin D insufficiency impairs the effect of alendronate for the treatment of osteoporosis in postmenopausal women [Abstract]","volume":"20","author":"Ishijima M","year":"2005","journal-title":"J Bone Miner Res"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050175"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-0290"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-004-1770-7"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199803193381201"},{"key":"e_1_2_7_35_2","first-page":"399","volume-title":"Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism","author":"Pettifor J.","year":"2004"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2006.00696.x"}],"container-title":["Journal of the American Geriatrics Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1532-5415.2007.01161.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/agsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1532-5415.2007.01161.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T20:10:35Z","timestamp":1762200635000},"score":1,"resource":{"primary":{"URL":"https:\/\/agsjournals.onlinelibrary.wiley.com\/doi\/10.1111\/j.1532-5415.2007.01161.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4,11]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["10.1111\/j.1532-5415.2007.01161.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1532-5415.2007.01161.x","archive":["Portico"],"relation":{},"ISSN":["0002-8614","1532-5415"],"issn-type":[{"value":"0002-8614","type":"print"},{"value":"1532-5415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4,11]]}}}